NYAX
Nayax Ltd.
NYAX's outlook is improving, though it still trails on the overall score.
SNDK
Sandisk Corporation
SNDK has the edge over NYAX overall, supported by stronger modeled upside and stronger fundamentals.
NYAX Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Stable | |
| Healthy | |
| Healthy |
NYAX's revenue, cash flow and balance sheet are currently healthy, and its profitability is stable.
SNDK Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Strong | |
| Strong | |
| Strong |
SNDK's revenue, profitability, cash flow and balance sheet are all currently strong.
NYAX PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 48x | $52.18 | — |
| Cheap | 66x | $13.83 | -73% |
| Fair | 82x | $17.22 | -67% |
| Expensive | 228x | $47.78 | -8.4% |
| Current | 246x | $52.18 | — |
Historical ranges are pointers, not guarantees.
NYAX's PE is in its expensive range at 246x. If earnings grow as analysts expect, today's price would be 48x next year's earnings, in its cheap range.
SNDK PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 3.8x | $937 | — |
| Current | 7.5x | $937 | — |
| Cheap | 17x | $2,173 | +132% |
| Fair | 24x | $3,048 | +225% |
| Expensive | 59x | $7,452 | +695% |
Historical ranges are pointers, not guarantees.
SNDK has the edge over NYAX in the historical PE scenario, which offers more potential upside but is not a forecast.
NYAX Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Improving | |
| Limited | |
| Moderate |
Analysts expect strong earnings and revenue growth for NYAX, with profitability improving.
SNDK Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Strongly improving | |
| Moderate | |
| High |
Analysts expect strong earnings and revenue growth for SNDK, with profitability improving.
NYAX Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.09 | +420% |
| Q2 2026 | $0.21 | -63% |
| Q1 2026 | $0.79 | +339% |
| Q4 2025 | $0.96 | +$1.13 |
| Q3 2025 | $0.65 | +$0.96 |
| Q2 2025 | $0.57 | +$1.00 |
| Q1 2025 | $0.18 | +$0.64 |
| Q4 2024 | -$0.17 | +$0.31 |
| Q3 2024 | -$0.31 | +$0.30 |
NYAX earned $0.21 per share over the past year, down 63% from the year before.
SNDK Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $247.30 | +97% |
| Q3 2026 | $125.61 | +$137.63 |
| Q2 2026 | $73.76 | +$85.07 |
| Q2 2025 | -$11.31 | -$6.65 |
SNDK has the edge over NYAX in the latest year-over-year earnings comparison.
NYAX Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $122.6M | +28% |
| Q1 2026 | $105.9M | +31% |
| Q4 2025 | $121.9M | +37% |
| Q3 2025 | $105.8M | +27% |
| Q2 2025 | $95.6M | +22% |
| Q1 2025 | $81.1M | +27% |
| Q4 2024 | $89M | +27% |
| Q3 2024 | $83M | +38% |
NYAX's revenue has grown year over year every quarter since early 2021: $123M last quarter, up 28% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | -5.4% | -15 points |
| Q1 2026 | 3.9% | -5.9 points |
| Q4 2025 | 11% | +6.9 points |
| Q3 2025 | 8.3% | +6.5 points |
| Q2 2025 | 10% | +8.8 points |
| Q1 2025 | 9.7% | +14 points |
| Q4 2024 | 4% | +5.9 points |
| Q3 2024 | 1.8% | +4.2 points |
NYAX's operating margin was −5.4% last quarter, down 15 points from the same quarter a year ago.
SNDK Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $11B | +378% |
| Q2 2026 | $9B | +372% |
| Q1 2026 | $6B | +251% |
| Q4 2025 | $3B | +61% |
| Q3 2025 | $2.3B | +23% |
| Q2 2025 | $1.9B | +8% |
| Q1 2025 | $1.7B | -0.6% |
| Q4 2024 | $1.9B | +13% |
SNDK's revenue has grown year over year for six quarters in a row: $11B last quarter, up 378% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 80% | +72 points |
| Q2 2026 | 78% | +78 points |
| Q1 2026 | 69% | +180 points |
| Q4 2025 | 35% | +25 points |
| Q3 2025 | 7.6% | -9 points |
| Q2 2025 | 0.9% | N/A |
| Q1 2025 | -111% | -122 points |
| Q4 2024 | 10% | +6.6 points |
SNDK has the edge over NYAX on profitability, with a higher operating margin.
NYAX Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | -$3.7M | -167% |
| Q1 2026 | $977.3K | +$6.7M |
| Q4 2025 | $16.3M | +76% |
| Q3 2025 | $15.5M | +53% |
| Q2 2025 | $5.6M | +91% |
| Q1 2025 | -$5.7M | -$1.3M |
| Q4 2024 | $9.3M | +$10.8M |
| Q3 2024 | $10.1M | +1431% |
NYAX usually generates cash, though not every quarter: the latest was −$4M, but it generated $29M over the past year.
SNDK Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $6.3B | +1340% |
| Q2 2026 | $7.1B | +14355% |
| Q1 2026 | $3B | +$3B |
| Q3 2025 | $438M | +$636M |
| Q2 2025 | $49M | +$217M |
| Q1 2025 | -$18M | +$23M |
| Q3 2024 | -$198M | -$157M |
SNDK generated $17.4B in free cash flow over the past year, more than ten times what it generated the year before.
NYAX Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -9.6% | -4M shares |
| 1 year | -0.6% | -211K shares |
| 3 years | +14% | +4.6M shares |
| 5 years | +23% | +7.1M shares |
| Available history | +51% | +12.7M shares |
NYAX has the edge over SNDK on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
NYAX hasn't bought back shares in the past year.
SNDK Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.6% | -1M shares |
| 1 year | +3.4% | +5M shares |
| 3 years | +6.9% | +10M shares |
SNDK has 154M diluted shares, up 3.4% from a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | $5B |
| Q3 2024 | — |
| Q2 2024 | — |
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
NYAX Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | 1.0x | Healthy |
| Q1 2026 | -0.9x | Net Cash |
| Q4 2025 | -1.0x | Net Cash |
| Q3 2025 | -1.5x | Net Cash |
| Q2 2025 | -0.2x | Net Cash |
| Q1 2025 | -0.7x | Net Cash |
| Q4 2024 | -1.1x | Net Cash |
| Q3 2024 | -0.5x | Net Cash |
NYAX's net debt is about a year of its operating earnings (EBITDA), after holding more cash than debt a year ago.
SNDK Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.2x | Net Cash |
| Q2 2026 | -0.4x | Net Cash |
| Q1 2026 | -0.7x | Net Cash |
SNDK has the edge over NYAX on leverage, with a lower net debt burden relative to earnings.
NYAX Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 48.5 | Neutral |
| Stochastic | 28.3 | Neutral |
NYAX's weekly RSI is 48 (neutral) and its Stochastic is 28 (neutral).
SNDK Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 40.2 | Neutral |
| Stochastic | 10.6 | Oversold |
SNDK's weekly RSI is 40 (neutral) and its Stochastic is 11 (oversold).
NYAX PE vs Technology Sector
| Metric | NYAX | Sector median | Relative |
|---|---|---|---|
| PE | 246x | 28x | 781% above |
| PE % | 91 | 40 | 51 pts above |
NYAX is trading at 246x earnings, a 781% premium to the Technology sector's median of 28x.
SNDK PE vs Technology Sector
| Metric | SNDK | Sector median | Relative |
|---|---|---|---|
| PE | 7.5x | 28x | 73% below |
| PE % | 4 | 27 | 23 pts below |
SNDK has the edge over NYAX on valuation relative to its sector.
NYAX Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $47.7 | 9.3% above |
| 20 week MA | $54.0 | 3.4% below |
| 50 week MA | $57.2 | 8.8% below |
| 100 week MA | $49.3 | 5.8% above |
| 200 week MA | $36.0 | 45% above |
NYAX has stronger trend alignment. NYAX is above 3 of 5 weekly averages versus SNDK above 0 of 3.
SNDK Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1,317.5 | 29% below |
| 20 week MA | $1,465.4 | 36% below |
| 50 week MA | $1,119.6 | 16% below |
SNDK is in a downtrend: it's below all three of its weekly moving averages, and 16% below its 50-week average.
NYAX Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2022 | $26.5 | $19.7 | -26% |
| 2023 | $19.7 | $19.1 | -3.3% |
| 2024 | $19.1 | $27.8 | +46% |
| 2025 | $27.8 | $48.3 | +74% |
| 2026 YTD | $48.3 | $52.2 | +8% |
NYAX has finished lower in two of the last four years. It's up 8% so far in 2026.
SNDK Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2025 | $50.4 | $250.1 | +396% |
| 2026 YTD | $250.1 | $937.5 | +275% |
SNDK has the edge over NYAX on returns for 2026, with the stronger performance.